| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/14/2005 | EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride |
| 12/14/2005 | EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/14/2005 | EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 12/14/2005 | CN1231495C Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 12/14/2005 | CN1231260C Hemostatic |
| 12/14/2005 | CN1231240C Rose and donkey-hide gelatin syrup and its preparation |
| 12/13/2005 | US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents; |
| 12/13/2005 | US6974809 Inhibitors of interleukin 1-β converting enzyme |
| 12/13/2005 | US6974800 Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor |
| 12/13/2005 | US6974795 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 12/13/2005 | US6974794 trolox bound to hemoglobin; biocompatible oxygen transporting molecules coupled with antioxidants; for protection of red blood cells (RBCs) against lysis. |
| 12/13/2005 | CA2280151C Arylsulfonyl hydroxamic acid derivatives |
| 12/13/2005 | CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 12/08/2005 | US20050273047 System and method for transdermal delivery of an anticoagulant |
| 12/08/2005 | US20050272806 Injectable formulations of taxanes for cad treatment |
| 12/08/2005 | US20050272789 Triazole-derived kinase inhibitors and uses thereof |
| 12/08/2005 | US20050272783 Amino acids with affinity for the alpha2delta-protein |
| 12/08/2005 | US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 12/08/2005 | US20050272715 Optically active dihydropyridine derivative |
| 12/08/2005 | US20050272669 treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. -[(4-{3-[N-(Carbamoylmethyl)-N-(methanesulfonyl)amino]-propoxy}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/08/2005 | US20050272148 Method of collecting placental stem cells |
| 12/08/2005 | US20050271673 Trifunctional reagent for conjugation to a biomolecule |
| 12/08/2005 | US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/08/2005 | US20050271652 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 12/08/2005 | US20050269722 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 12/08/2005 | DE102004024241A1 Water-soluble starch acetate useful in biomedical, pharmaceutical and food applications, especially as a blood plasma expander |
| 12/08/2005 | CA2567961A1 Superloaded liposomes for drug delivery |
| 12/07/2005 | EP1602667A1 Aqueous formulation comprising TFPI and solubilising agents |
| 12/07/2005 | EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists |
| 12/07/2005 | EP1602657A2 Substituted 9-alkyladenines |
| 12/07/2005 | EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors |
| 12/07/2005 | EP1602380A1 Preventive/remedy for diseases in upper digestive tract |
| 12/07/2005 | EP1602372A1 Drug for improving prognosis for subarachnoid hemorrhage |
| 12/07/2005 | EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 12/07/2005 | EP1601380A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| 12/07/2005 | EP1601379A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 12/07/2005 | EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 12/07/2005 | EP1450800A4 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS |
| 12/07/2005 | EP1379528A4 Pyrazolopyrimidines as therapeutic agents |
| 12/07/2005 | EP1307449B1 1,4-dihydropyridines as bradykinin antagonists |
| 12/07/2005 | EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 12/07/2005 | EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines |
| 12/07/2005 | EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 12/07/2005 | EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 12/07/2005 | EP1155019B1 Substituted porphyrins and their therapeutic use |
| 12/07/2005 | EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases |
| 12/07/2005 | EP1038524B1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof |
| 12/07/2005 | EP1030567B9 System for dialysis and shock treatment |
| 12/07/2005 | EP0922105B1 Infectious papillomavirus pseudoviral particles |
| 12/07/2005 | CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram |
| 12/07/2005 | CN1705490A Plasma preparation or serum preparation and process for producing the same |
| 12/07/2005 | CN1704401A Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1230449C Heparin-derived polysaccharide mixtures, prepn. method and pharmaceutical compsns. contg. same |
| 12/07/2005 | CN1230418C Selective androgen receptor modulators and methods of use thereof |
| 12/07/2005 | CN1230245C Cartridges useful in cleaning dialysis solutions |
| 12/07/2005 | CN1230201C Blood-platelet specific mosaic immune globulin and its using method |
| 12/07/2005 | CN1230196C Erythropoiesis for treating anemia of family and raised animals |
| 12/07/2005 | CN1230193C Water-purging pill |
| 12/07/2005 | CN1230179C Micronized eplerenone compositions |
| 12/07/2005 | CN1230175C Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method |
| 12/07/2005 | CN1230172C Blood circulation improving agent |
| 12/07/2005 | CN1230159C Essential fatty acids in prevention of cardiovascular events |
| 12/07/2005 | CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof |
| 12/07/2005 | CN1230150C Slow release pharmaceutical compositions comprising lithium carbonate |
| 12/06/2005 | US6972298 Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor |
| 12/06/2005 | CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof |
| 12/02/2005 | CA2509077A1 Water-based compositions comprising a polyethylene glycol-based solubilizing agent and a taxane useful in the treatment of coronary artery disease |
| 12/01/2005 | WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 12/01/2005 | WO2005113030A1 Tissue closing preparation |
| 12/01/2005 | WO2005113009A1 Solid pharmaceutical formulation |
| 12/01/2005 | US20050267189 Celecoxib compositions |
| 12/01/2005 | US20050267165 Il-8 receptor antagonists |
| 12/01/2005 | US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 12/01/2005 | US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 12/01/2005 | US20050267112 intravenous or oral administration; hypotensive agents; enzyme inhibitors of cGMP-metabolizing phosphodiesterases |
| 12/01/2005 | US20050267097 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 12/01/2005 | US20050267033 Multi-dose erythropoietin formulations |
| 12/01/2005 | US20050267014 Pharmaceutical composition comprising factor VII polypeptides and tranexamic acid |
| 12/01/2005 | US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders |
| 12/01/2005 | US20050266532 Albumin fusion proteins |
| 12/01/2005 | US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant |
| 12/01/2005 | US20050266020 Modular transport systems for molecular substances and production and use thereof |
| 12/01/2005 | US20050266013 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood |
| 12/01/2005 | US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies |
| 12/01/2005 | CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 12/01/2005 | CA2567297A1 Tissue sealant |
| 12/01/2005 | CA2566081A1 Use of dipyridamole for treatment of resistance to platelet inhibitors |
| 12/01/2005 | CA2565029A1 Immediate release pharmaceutical tablets with height greater than width |
| 11/30/2005 | EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 11/30/2005 | EP1600180A2 Antiproliferative drug and delivery device |
| 11/30/2005 | EP1599715A2 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 11/30/2005 | EP1599600A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 11/30/2005 | EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives |
| 11/30/2005 | EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 11/30/2005 | EP1599258A1 Fumed silica embolic compositions |
| 11/30/2005 | EP1465892A4 Glycinamides as factor xa inhibitors |
| 11/30/2005 | EP1363882A4 3-(3-amidinophenyl)-5- ( 1-(1-(-iminoethyl)-4-piperidyl amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
| 11/30/2005 | EP1335932B1 Isolation of lectins |
| 11/30/2005 | EP1282439B1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |